In August 2016, BMI SYSTEM participated in two congresses: the 10th Transparency & Aggregate Spend Congress in Washington DC and the 2nd Annual Pharmaceutical Compliance in Latin America Congress in Sao Paulo, Brazil.
In the United States
For the first time in the USA, BMI SYSTEM & Meeting Events International (MEI) co-branded the stand during the 10th Transparency & Aggregate Spend Congress. Both companies combined their in-depth complementary skills to provide Pharmaceutical and Medical Device companies with a global & flexible solution ranging from Speaker bureau & event management to world class compliance & transparency solutions, in the United States as well as in Europe.
The main themes discussed during the 10th Transparency & Aggregate Spend Congress in Washington were:
- The impact of the EFPIA Disclosure Code and Open Payments Reporting on U.S and European Meetings and Event Management
- How to Use Data Analytics to Assess Compliance Risks
The various conferences highlighted the importance of “big data analytics” and how enforcement driven transparency initiatives are driving significant energy and resources into global compliance monitoring.
The main themes discussed during the 2nd Annual Pharmaceutical Compliance in Latin America Congress in Sao Paulo were:
- How Pharmaceutical Companies and Patients Associations can work together
- The future of compliance in LATAM
- Compliance in Market Researches
With different approaches to compliance and transparency in different countries, this congress gave the opportunity to multinationals to share best practices, optimize relations with HCPs and HCOs and prepare for upcoming disclosure. Colombia will be handling its first disclosure next year, followed by Argentina.
For further information on these, or any other transparency and compliance related issues, we invite you to contact us: